Our Global Voices Posts

A life-long career dedicated to protecting people against mosquito borne diseases

Posted on by Audrey Lenhart, Research Entomologist
Bill conducting human landing collections of malaria vectors
Bill conducting human landing collections of malaria vectors

Many people don’t choose a career path until after college, or even after a few years of working in a particular field. But then, many are not like my former colleague, Dr. William (Bill) Brogdon.

Bill first entered the doors of the Centers for Disease Control and Prevention as a 17-year-old high school student and asked for a job.  Soon after, he was put to work in one of the agency’s environmental health labs, a pivotal moment that launched a 50-year long career in the service of protecting the public’s health.

Armed with his training and expertise in entomology, biochemistry, molecular biology, and molecular genetics, Bill quickly demonstrated his talents by innovating methods used to detect and assess insecticide resistance in mosquitoes and other insects that spread diseases like malaria, dengue, and Zika.

Over the course of his career, Bill developed new and improved ways to monitor insecticide resistance, focusing mosquitoes that transmit one of the most deadly diseases: malaria. Despite increased efforts to control diseases, we are seeing widespread increases in insecticide resistance across the world.  This poses a major threat to our ability to control malaria and other mosquito-borne diseases…

Today, Bill’s methods continue to be used around the world to identify the ways mosquitoes become resistant to insecticides. Control programs use this  critical information to choose cost effective insecticides and to ensure the chemicals used in insecticide-treated bed nets, or for indoor spraying of homes, remain effective in preventing mosquito bites – and thus, preventing the spread of serious diseases.

One of these tools, the CDC Bottle Assay, has emerged as an international standard.  This technique is used to conduct mosquito insecticide resistance testing in more than 30 countries, including those supported by the U.S President’s Malaria Initiative.

Dr. Bill Brogdon (center) along with USN CAPT (retired) David Hoel and National Malaria Control Program staff at PMI Entomology Training in Uganda, 2015
Dr. Bill Brogdon (center) along with USN CAPT (retired) David Hoel and National Malaria Control Program staff at PMI Entomology Training in Uganda, 2015

Recognizing his expertise, Bill was invited to serve on the World Health Organization’s (WHO) Expert Committee for Vector Control.  He also led the WHO Collaborating Centre for Insecticide/Formulation Evaluation at CDC.  Over the years, he continued to advance the field with development of novel assays using loop mediated isothermal amplification (LAMP/RT-LAMP), a technique to amplify genetic material, with an eye towards assessing whether this method could be used for practical field surveillance and analysis of insecticide resistance in low resource, “real world” settings.  One of Bill’s most striking attributes was his ability to creatively adapt the latest scientific knowledge to field-relevant scenarios.  Indeed, his legacy of simple, elegant, and readily accessible techniques can be seen in nearly every laboratory in the world that conducts surveillance on mosquito insecticide resistance.

Bill retired from government service in 2019, bringing his illustrious CDC journey to a close. However, colleagues and experts like him, including myself, continue to grow his legacy.  CDC is a leading international resource on vector control, insecticide resistance, and vector surveillance.  We remain firmly committed in our role to assist countries, states, and other public health partners to build capacity to detect, monitor, and mitigate the spread of insecticide resistance.  For example, CDC is using Advanced Molecular Detection (AMD) methods to develop novel tools to detect and manage insecticide resistance in mosquitoes that spread diseases such as malaria, dengue, and Zika. Having rapid, field-friendly diagnostic assays that can detect resistance at its earliest stages is critical because the faster we can detect resistance, the better we can prevent it from spreading so we don’t risk losing some of our most effective, life-saving tools.

Bill understood the importance of this mission. After all, he dedicated his whole career to it.

Audrey Lenhart is a research entomologist in the Entomology Branch of the Division of Parasitic Diseases and Malaria. In addition to leading the branch’s Insecticide Resistance and Vector Control Team, she coordinates CDC’s entomology activities in the USAID-funded Latin America and Caribbean Malaria Program and manages CDC’s portfolio of international vector-related activities for Zika.


Posted on by Audrey Lenhart, Research EntomologistLeave a commentTags , , , ,

Controlling hepatitis B in Sierra Leone

Lisa Breakwell

The leading cause of liver cancer worldwide is hepatitis B virus (HBV). Sierra Leone is thought to have a high percentage, at least 8%, of the population actively infected with HBV. Some studies report that in Sierra Leone, 6% to 11% of pregnant women have active HBV infection, which they can transmit to their babies Read More >

Posted on by Lucy Breakwell, GIDLeave a commentTags ,

Three Responders talk about their experiences in Uganda

Protecting Uganda’s Border Vance Brown, Ebola Coordinator and Deputy Director for the Division of Global Health Protection Program in Uganda. Vance and team provide technical support to the Government of Uganda to prevent, detect and respond to especially dangerous pathogens, including Ebola. “It was 8:00 p.m. on a Friday when I got the call. CDC Read More >

Posted on by JeffLeave a commentTags , , ,

The Joint External Evaluation (JEE) Process: Assessing health security in Côte d’Ivoire

Serigne Ndiaye, CDC GHSA Program Director for Cote d'Ivoire, center, meets with community leaders

Conducting a JEE Côte d’Ivoire (Ivory Coast) is a small country in West Africa, neighboring Liberia, Guinea, Mali, Burkina Faso, and Ghana. It has a population of over 25 million people, about half of whom live in urban centers across the country. Diseases of great concern for the country include yellow fever, cholera, meningitis, measles, Read More >

Posted on by Serigne Ndiaye, CDC GHSA Program DirectorLeave a commentTags , , , , , ,

Taking Back the Lives That Tobacco Use Cuts Short: One Story from a Physician in Senegal

I went into medicine because I am passionate about helping others. I became an oncologist, a doctor who cares for people with cancer, because it gives me the opportunity to save lives and improve a patient’s health care every day. I practice in Senegal, my beautiful country of origin in West Africa. As a young Read More >

Posted on by Dr. Oumar Ba, Oncologist, Hôpital General Grand Yoff, DakarLeave a comment

Confronting the Silent Killer in Nepal

May Measurement Month volunteers screen local resident outside of a temple in Pokhara, Nepal. Photo credit: Kiran Adhikari

“We are measuring the blood pressure of many people who’ve never had their blood pressure measured before,” explains Dr. Dinesh Neupane, the country coordinator for May Measurement Month in Nepal. “When we approach people about being screened, we often hear that they don’t need their blood pressure checked because they feel healthy.” But Dr. Neupane Read More >

Posted on by Bethany HallLeave a commentTags , , , ,

Tracking Lassa Fever Across Three Countries

Tracking Lassa Fever Across Three Countries

  When a Beninese migrant worker fell ill in Nigeria in December 2017, he decided to return to his parents’ home in Togo for care. His condition deteriorated during his trip through Benin. On his trip he stopped at Tandou Health Center in Tchaourou, Benin, was attended to by two healthcare workers, and continued his Read More >

Posted on by By Lesley Chace, MPH CDC FETP Lead - Francophone West AfricaTags , , , , , ,

From Mangoes to Meningitis: A Tale of One Laboratory Scientist in Burkina Faso

Rasmata Ouédraogo Traoré

Rasmata Ouédraogo-Traoré PhD is the Chief of the Medical Analysis Laboratory of the Charles De Gaulle Pediatric Hospital, which houses the National Reference Laboratory for meningitis in Burkina Faso, and a professor of bacteriology-virology, medical sciences and pharmacy at the University of Ouagadougou. A concerned mother in Burkina Faso says to me, “I think that Read More >

Posted on by Professor Rasmata Ouédraogo-Traoré, PhDTags , , ,

Overcoming Refusals to Polio Vaccination in Uttar Pradesh, India

In 2014, WHO South-East Asia Region (SEAR) became the fourth region, among WHO’s six regions, to be certified as having interrupted all wild polio virus (WPV) circulation. India was the last country to eliminate polio in SEAR, proving that polio could be eradicated in the most challenging settings. Multiple international partners collaborated with Government of Read More >

Posted on by Alford (A.J.) Williams, Public Health Advisor, Global Immunization Division

I have seen Ebola. Now you have a vaccine.

Debut of preventive use of Ebola Virus Disease (EVD) vaccine for health care and frontline workers in Uganda before an outbreak For the first time, an unlicensed Ebola vaccine tested in clinical trials during the West African outbreak was offered to health care workers (HCWs) and other front line workers (FLWs) working in facilities bordering Read More >

Posted on by Rosalind Carter-Epidemiologist, Global Immunization Division